I am a hematologist/oncologist who specializes in the research and treatment of patients with a variety of myeloid malignancies. These include myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.
I currently spend the majority of my time in laboratory-based research investigating the underlying causes of these disorders through genomic studies of patient samples as well as in vitro and in vivo models. As a member of the laboratory of Ross Levine in the Human Oncology and Pathogenesis Program, I have helped to identify and characterize several new genetic abnormalities in the diseases mentioned above. In addition to increasing our understanding of the causes of these disorders, these discoveries have promise in helping to discover novel targeted therapies.
- Clinical Expertise: Myeloid Malignancies (myloproliferative neoplasms, myelodysplasia, acute myeloid leukemia)
- Languages Spoken: English
- Education: MD, Duke University
- Residencies: Internal Medicine - Massachusetts General Hospital
- Fellowships: Hematology/Oncology - Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more